Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dosage and administration of anti-EGFR therapeutics

Dosage and administration of anti-EGFR therapeutics

US Patent 9920131 · Granted Mar 20, 2018

Estimated economic value: $1,756,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

RET inhibitor for use in treating cancer having a RET alteration2024
RET inhibitor for use in treating cancer having a RET alteration2024
RET inhibitor for use in treating cancer having a RET alteration2022
Diagnostic assays and kits for detection of folate receptor 12020
Diagnostic assays and kits for detection of folate receptor 12019
Antibodies against epidermal growth factor receptor (EGFR) and uses thereof2018
Antibodies against epidermal growth factor receptor (EGFR) and uses thereof2018
Antibodies against epidermal growth factor receptor (EGFR) and uses thereof2018
Diagnostic assays and kits for detection of folate receptor 12017
Dosage and administration of anti-EGFR therapeutics2017
Dosage and administration of anti-EGFR therapeutics2017
Antibodies against epidermal growth factor receptor (EGFR) and uses thereof2016